Scopolamine Prevents Mitochondrial Dysfunction in Depressive Disorder, Potentially via Its Anti-Inflammatory Effects
Background Depression imposes a heavy global disease burden accompanied by mitochondrial injury and neuroinflammation predominantly in the prefrontal cortex. Using a chronic unpredictable mild stress (CUMS) rat model, this study aimed to explore the impacts of scopolamine on brain mitochondrial function and its underly...